2011-11-15 18:18 Innovation Pioneers International AB
Tag: commercialize
3träffar
Pressmeddelanden
2011-09-15 09:00 Uppsala BIO Swedish life science initiative Uppsala BIO has formed a strategic partnering agreement with Roche, for Uppsala BIO’s open innovation program, BIO-X. The BIO-X program identifies and supports ideas in the research community that can satisfy unmet medical needs or solve problems in healthcare, drug development, and diagnostics. The agreement is the first of its kind in Europe.
2010-06-23 08:30 Medivir AB GlaxoSmithKline (GSK) and Medivir (STO: MVIR-B) today announced an exclusive agreement for the commercialization of cold sore treatment, Xerclear™ (acyclovir and hydrocortisone) for non-prescription use (OTC) in key global markets. Xerclear™ is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing.